View all Webinars

Schwegman Lundberg & Woessner

Close     Close Mobile Menu

Categories

Recent

New ChIPs Chapter Offers Opportunities for Twin Cities Women
Twin Cities women in technology, law and policy now have...
Schwegman Named in Top 25 Firms for Minority Attorneys
Schwegman Lundberg & Woessner is pleased to have been recognized...
2019 IAM Strategy 300
We are proud to announce that attorneys Russ Slifer, Timothy...
Innovation & Automation in the IP Law Firm
Today, we are all hearing about artificial intelligence’s impact on...
Third Annual AIPLA Diversity in IP Happy Hour Events
Schwegman hosted the Minneapolis and San Jose editions of the...
AUTM Central Region Meeting
The 2019 AUTM Central Meeting will be held at the...

Warren Woessner to Speak at Bio IP & Diagnostics Symposium

Warren Woessner, founding shareholder of Schwegman, will be speaking at the Bio IP & Diagnostics Symposium (Bio IPDx) on September 19, 2017, in Alexandria, VA.

Dr. Woessner will be speaking alongside Dr. Leslie Fischer of Novartis and Hans Sauer of Biotechnology Innovation Organization in a panel-style discussion titled “The Walls Are Closing In – The Bleak Future of Claims Reciting Natural ‘Correlations’ and Products of Nature.”  The three will discuss how recent developments regarding section 101 may once again increase patentability in this technology space.

Warren’s practice focuses on chemical patent law, including biotechnology, pharmaceuticals, vaccines, medical treatments, diagnostics, and biofuels and agricultural chemistry, including related opinion and licensing matters. In addition, he has served as an expert witness and also works in mediation of inventorship disputes and solutions for complex prosecution problems.

This seminar will be held at the Westin Alexandria from 7:30 am – 2:15 pm.

Register Here

 

  Back to All News